By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – SuperNova Diagnostics today said that it has signed a collaboration agreement with Shenzhen Kang Bao Bio-Technology.

The Germantown, Md.-based startup did not say what functions KSB Diagnostics will be performing on its behalf, but noted that the Hong Kong firm specializes in the research, manufacture, and distribution of in vitro diagnostic kits and research reagents in China and other markets in the area.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.